Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Titus

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Prostate|October 24, 2013
5α-reductase type 3 enzyme in benign and malignant prostateMark A Titus, Yun Li, Olga G Kozyreva, et al.
The Prostate|May 11, 2011
5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progressionAlejandro Godoy, Elzbieta Kawinski, Yun Li, et al.
Cancer Research|February 10, 2011
Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancerJames L Mohler, Mark A Titus, Suxia Bai, et al.
Translational Oncology|September 17, 2008
Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate CancerSwaroop S Singh, Yun Li, Oscar Harris Ford, et al.
Cancer Research|March 25, 2018
Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell CarcinomaRemi Adelaiye-Ogala, Nur P Damayanti, Ashley R Orillion, et al.
Analytical Chemistry|June 10, 2021
Parallel, High-Quality Proteomic and Targeted Metabolomic Quantification Using Laser Capture Microdissected TissuesShichen Shen, Jun Li, Shihan Huo, et al.
Plos One|January 25, 2012
Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancerMark A Titus, Brian Zeithaml, Boris Kantor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate CancerMark A Titus, Jiann-An Tan, Christopher W Gregory, et al.
Molecular and Cellular Endocrinology|October 10, 2013
Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancerJiann-An Tan, Suxia Bai, Gail Grossman, et al.
Scientific Reports|October 18, 2016
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate CancerSankar N Maity, Mark A Titus, Revekka Gyftaki, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Prostate|October 24, 2013
5α-reductase type 3 enzyme in benign and malignant prostateMark A Titus, Yun Li, Olga G Kozyreva, et al.
The Prostate|May 11, 2011
5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progressionAlejandro Godoy, Elzbieta Kawinski, Yun Li, et al.
Cancer Research|February 10, 2011
Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancerJames L Mohler, Mark A Titus, Suxia Bai, et al.
Translational Oncology|September 17, 2008
Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate CancerSwaroop S Singh, Yun Li, Oscar Harris Ford, et al.
Cancer Research|March 25, 2018
Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell CarcinomaRemi Adelaiye-Ogala, Nur P Damayanti, Ashley R Orillion, et al.
Analytical Chemistry|June 10, 2021
Parallel, High-Quality Proteomic and Targeted Metabolomic Quantification Using Laser Capture Microdissected TissuesShichen Shen, Jun Li, Shihan Huo, et al.
Plos One|January 25, 2012
Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancerMark A Titus, Brian Zeithaml, Boris Kantor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate CancerMark A Titus, Jiann-An Tan, Christopher W Gregory, et al.
Molecular and Cellular Endocrinology|October 10, 2013
Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancerJiann-An Tan, Suxia Bai, Gail Grossman, et al.
Scientific Reports|October 18, 2016
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate CancerSankar N Maity, Mark A Titus, Revekka Gyftaki, et al.
Pageof 3